Sale!

PD-L1 Genetic Test Cost

Original price was: 11,200 د.إ.Current price is: 8,400 د.إ.

-25%

The PD-L1 genetic test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to evaluate the expression of the Programmed Death-Ligand 1 (PD-L1) gene. PD-L1 is a protein that plays a crucial role in suppressing the immune system, particularly in the context of cancer, by interacting with the PD-1 receptor on T cells. This interaction helps cancer cells evade immune detection and destruction. The test is particularly valuable for patients with certain types of cancer, as it helps oncologists determine the likelihood of response to immunotherapy treatments targeting the PD-1/PD-L1 pathway.

The process involves analyzing a sample of the patient’s tumor tissue to measure the level of PD-L1 expression. High levels of PD-L1 may indicate that the patient is more likely to benefit from PD-1/PD-L1 inhibitor therapies, which can block this interaction and enhance the immune system’s ability to fight cancer.

At DNA Labs UAE, the PD-L1 genetic test is conducted with precision and care, ensuring reliable results for patients and their healthcare providers. The cost of the test is 8400 AED, reflecting the sophisticated technology and expertise required to perform this advanced genetic analysis. By offering this test, DNA Labs UAE plays a crucial role in the personalized treatment of cancer, enabling more targeted and effective therapies based on the genetic profile of each patient’s tumor.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PDL1 Genetic Test Cost AED: 8400.0

Welcome to DNA Labs UAE, where we offer the PDL1 Genetic Test at a cost of 8400.0 AED. This test is essential for diagnosing certain genetic conditions and determining the effectiveness of PDL1 inhibitors in cancer treatment.

Test Name: PDL1 Genetic Test

Components:

  • Properly packed and previously labelled slides and blocks with clinical details
  • Proper requisition form

Price: 8400.0 AED

Sample Condition: Blocks

Report Delivery: 7-8 days

Method: IHC

Test Type: Genetics

Doctor: Oncology

Test Department:

Before undergoing the PDL1 Genetic Test, it is important to be aware of the following pre-test information:

  • PDL1 (DAKO) can be done with a doctor’s prescription.
  • Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.

Test Details

PDL1 (Programmed Death-Ligand 1) is a protein found on the surface of certain cells in the body, including some cancer cells. It plays a crucial role in regulating the immune system by interacting with a protein called PD-1 on T cells. When PDL1 binds to PD-1, it sends a signal to the T cell to stop attacking the cell that has PDL1 on its surface.

This mechanism is exploited by cancer cells to evade the immune system and avoid destruction. To counter this, PDL1 inhibitors, a type of cancer immunotherapy, are used. These inhibitors block the interaction between PDL1 and PD-1, enabling T cells to recognize and attack cancer cells.

PDL1 inhibitors have been approved for the treatment of various types of cancer, such as melanoma, lung cancer, bladder cancer, and kidney cancer. However, it is important to note that not all patients respond to PDL1 inhibitors, and researchers are actively working to understand why some tumors are resistant to this type of therapy.

Test Name PDL1 Genetic Test
Components Properly packed and previosly labelled slides and blocks with clinical details and proper requisition form
Price 8400.0 AED
Sample Condition Blocks
Report Delivery 7-8 days
Method IHC
Test type Genetics
Doctor Oncology
Test Department:
Pre Test Information PDL1 DAKO] can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

PDL1 (Programmed Death-Ligand 1) is a protein that is found on the surface of certain cells in the body, including some cancer cells. It is involved in regulating the immune system by interacting with a protein called PD-1 on T cells. When PDL1 binds to PD-1, it sends a signal to the T cell to stop attacking the cell that has PDL1 on its surface. This mechanism is used by cancer cells to evade the immune system and avoid destruction.

PDL1 inhibitors are a type of cancer immunotherapy that work by blocking the interaction between PDL1 and PD-1, allowing T cells to recognize and attack cancer cells. PDL1 inhibitors have been approved for the treatment of several types of cancer, including melanoma, lung cancer, bladder cancer, and kidney cancer. However, not all patients respond to PDL1 inhibitors, and researchers are still working to understand why some tumors are resistant to this type of therapy.